Skip to content

Auricular acupuncture combined with percutaneous auricular electrical stimulation for endocrine therapy-associated insomnia in breast cancer patients: assessor-participant blinded

Auricular acupuncture combined with percutaneous auricular electrical stimulation for endocrine therapy-associated insomnia in breast cancer patients: randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076863
Enrollment
Unknown
Registered
2023-10-23
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endocrine therapy-associated insomnia in breast cancer

Interventions

group 1:auricular acupuncture combined with percutaneous auricular electrical stimulation +psychological intervention
group 2:sham acupuncture+psychological intervention

Sponsors

Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Female, aged = 18 years and = 80 years; (2) Histopathologically diagnosed as stage I-III estrogen receptor (ER) - positive breast cancer and / or progesterone receptor (PR) - positive breast cancer, according to the Chinese society of clinical oncology breast cancer (CSCO BC) diagnosis and treatment guidelines (2022 version); (3) Currently receiving oral endocrine therapy drugs with a history of = 1 month, and plans to continue to receive endocrine therapy during the study period; (4) Meet the diagnostic criteria of breast cancer and insomnia; (5) The total score of Pittsburgh sleep quality index (PSQI) was > 7; (6) According to the Eastern Cooperative Oncology Group (ECoG) activity status score table, patients with a score of 0 or 1 ("0" stands for completely normal activity ability, without any difference from the activity ability before the onset; "1" stands for free walking and engaging in light physical activities, including general household or office work, but can not engage in heavy physical activities), their survival is predicted to be = 3 months; (7) Taking sedative hypnotic drugs stably for more than 1 month or not before entering this study; (8) Follow the principle of voluntariness, and sign the informed consent before entering the study.

Exclusion criteria

Exclusion criteria: (1) Patients who are currently receiving chemotherapy or radiotherapy or who have surgery plans during the protocol; (2) Patients with severe heart, liver and kidney function injury, respiratory, blood and mental system or combined with other tumor diseases; (3) Any current or past serious cardiovascular disease, or people who are not suitable for acupuncture treatment, such as: face or ear pain, ear trauma, metal implantation higher than the neck level, serious skin disease, allergic constitution; (4) Suffering from other sleep disorders: related to breathing, such as obstructive sleep apnea syndrome or restless legs syndrome of lower limbs, etc.: (5) Participated in other clinical research topics in the last 3 months. (6) She received acupuncture treatment for insomnia symptoms 1 month before the start of the study. (7) Ear diseases such as ulcers, abscesses, etc. cannot be carried out by the investigator.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index (PSQI);

Secondary

MeasureTime frame
Insomnia Severity Index scale (ISI);actigraph;Heart rate variability (HRV);Beck Anxiety Inventory (BAI);Beck Depression Inventory (BDI);Functional Assessment of Cancer Therapy (FACT);Functional Assessment of Cancer Therapy-Endocrine Symptom (FACT-ES);Epworth Sleepiness Scale (ESS);Credibility and expectancy;Sex Hormones;Inflammatory factors;Survival follow-up;Dosage taken during the study period;

Countries

China

Contacts

Public ContactJi Yajie

Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

2373602874@qq.com+86 133 0177 9329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026